CLAIM #48726 · Pfizer Inc (PFE) · 2026Q1 earnings call · May 5, 2026 · due Dec 31, 2026
“And I'm also very confident that we navigate the LOEs, as you saw right now, very well starting already this year, the LOEs.”
Albert Bourla · CEO
How to check this claim
Look at: Revenue from new and acquired products (offsetting LOE erosion), annual
It came true if: Full-year revenue from new/acquired products >= $12 billion, growth rate roughly in line with or above 22% year-over-year
Where: Company quarterly/annual earnings reports and management commentary (10-K / earnings call disclosures on product-line revenue)
In context
“ctions about the growth profile, which we said it is starting in '29, it's a 5-year high single-digit CAGR. How that is built is built with the current portfolio with the decline through the LOEs and with the additions of pipeline that they are heavy risk adjusted. So it's not that we are having [ binary ] events. So the pipeline are multiple, as you know. We have a series of readouts right now that will affect the revenues in the '29. And so I think when -- I feel confident about that because when it is a large number of pipeline assets risk adjusted, statistics usually work. And those that will fail will fail and those that will succeed will succeed, but the risk adjustment takes into consideration about that. So very confident about the growth trajectory of the company starting in '29. And I'm also very confident that we navigate the LOEs, as you saw right now, very well starting already this year, the LOEs. I also want to emphasize that always the strategy for LOEs was new and acquired products to do well because they were launched and acquired to offset the LOEs. They are growing 22% this year. They are already on $3.1 billion in a quarter. If you -- without saying that that's the guidance, but if you multiply by 4 just to give you [indiscernible], we are talking about over $12 billion this year and growing. And the $17 billion of LOEs now after [indiscernible], they are more $14 billion to $15 billion rather than $17 billion. So I think it's manageable. Operator: Our next question comes from Evan Seigerman with BMO Capital Markets. Evan Seigerman: I really want to touch on capital deployment, specifically when it comes to share repurchases. Dave, I know that, that's been a method that you”
Verify independently
SEC filings for PFE ↗ · Claim quote is verbatim from the 2026Q1 earnings call.